Association Among Chronic Obstructive Pulmonary Disease Severity, Exacerbation Risk, and Anxiety and Depression Symptoms in the SPIROMICS Cohort

By sjmartinez • February 15, 2023

Weiss JR, Serdenes R, Madtha U, Zhao H, Kim V, Lopez-Pastrana J, Eakin MN, O'Toole J, Cooper CB, Woodruff P, Kanner RE, Krishnan JA, Iyer AS, Couper D, Morrison MF. Association Among Chronic Obstructive Pulmonary Disease Severity, Exacerbation Risk, and Anxiety and Depression Symptoms in the SPIROMICS Cohort. J Acad Consult Liaison Psychiatry. 2023 Jan-Feb;64(1):45-57. doi: 10.1016/j.jaclp.2022.07.008. Epub 2022 Aug 7. PMID: 35948252.

Tags: anxiety, Chronic Obstructive Pulmonary Disease, depression, Global Initiative for Obstructive Lung Disease groups, hospital anxiety and depression scale, Publications, Pulmonary, Critical Care & Sleep Medicine, Subpopulations and Intermediate Outcome Measures in COPD Study

Related Posts

GLP-1 and Dual GLP-1/GIP Receptor Agonists in Heart Failure With Mildly Reduced or Preserved Ejection Fraction: A Systematic Review and Meta-Analysis

Ahmed M, Burhan M, Shafiq A, Hashmi TM, Ahmed R, Fudim M, Mentz RJ, Fonarow GC. GLP-1 and Dual GLP-1/GIP Receptor Agonists in Heart Failure[...]

Multicenter Study on the Safety of Pulsed Field Ablation in Over 40,000 Patients: MANIFEST-US

Turagam MK, Aryana A, Day JD, Dukkipati SR, Hounshell T, Nair D, Natale A, Weiner S, Cheung JW, Chinitz L, Cuoco F, Daccarett M, Dandamudi[...]

Preliminary insights into methylation patterns in Agent Orange exposed thyroid cancers: a pilot study

Amreen B, Lesseur C, Sadikki H, Saul SR, Kazi S, Leung AM, Nguyen EY, Monaghan M, Taioli E, Genden EM, Chen J, van Gerwen M.[...]